Zydus Lifesciences Ltd announced that it has been granted final approval by the FDA to produce paliperidone extended-release tablets in doses of 1.5 mg, 3 mg, 6 mg, and 9 mg. Paliperidone extended-release tablets are prescribed for treating...
In pharmaceutical plant design, explosion-proof safety management is a critical factor for ensuring safe and efficient operations. Given that pharmaceutical production often involves large quantities of flammable and explosive chemicals.
Amneal Pharmaceuticals, a US company, announced plans to pour USD 200 million (around Rs 1,680 crore) into India for constructing two new manufacturing units in Ahmedabad within the next four to five years. The company announced plans for two new...
Emcure Pharmaceuticals announced a royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC, a subsidiary of the California-based Gilead Sciences, to manufacture and supply generic versions of lenacapavir, the antiretroviral...
The Competition Commission of India (CCI) gave approval to Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore. Mankind Pharma, a publicly traded company, is involved in creating, producing, and selling a wide variety of...
Drug manufacturer Dr Reddy's Laboratories Ltd has invested $620 million into its wholly-owned branch, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment is consistent with the company's previous board-approved decision to invest up...
Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) to produce and sell Fruzaqla capsules 1mg/5mg (fruquintinib), an oral inhibitor of VEGFR-1, -2, and -3, for advanced or recurring colorectal cancer treatment...
Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..
Max Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of...
Eli Lilly announced that it will invest $1.8 billion in two manufacturing facilities in Ireland to increase production of its highly popular obesity medication and a recently approved treatment for Alzheimer's disease. The funding is a...